Offstream
news

---

Changes

1. Novavax says that they will pursue full approval for their COVID-19 vaccine during the second half of 2022.
   2022-03-01 01:06:17 (First version)
2. Novavax says that they will pursue full approval for their COVID-19 vaccine during the second half of this year.
   (Current version)

---

Related

The European Commission authorizes the use of the Novavax COVID-19 vaccine after the European Medicines Agency recommended the use of the vaccine, becoming the fifth vaccine to be approved for use by the European Union.
2021-12-20

Denmark confirms that it will purchase 280,000 doses of the Novavax COVID-19 vaccine for a total price of 37 million crowns ($5.84 million) or roughly $20.9 per dose as part of a European Union agreement with Novavax.
2021-08-11

The European Commission signs an agreement with Novavax to purchase 200 million doses of its protein-based COVID-19 vaccines, including an option to purchase another 100 million doses through 2023.
2021-08-4

India begins a COVID-19 vaccine registration for those over the age of 18.
2021-04-28

Polish biotechnology company Mabion S.A. signs an agreement with Novavax to begin commercial-scale production trials for Novavax's future vaccine.
2021-03-3

South Korea signs an agreement with Novavax and Pfizer to secure additional doses of the COVID-19 vaccine for 23 million people in the second quarter of this year.
2021-02-16

Ukraine secures 12 million doses of the vaccine developed by AstraZeneca and Novavax.
2021-02-5

Vaccine developer Novavax announces that their vaccine candidate is 89% effective in preventing severe COVID-19, based on trial data from the United Kingdom; their vaccine was less effective against new variants of the virus, based on data from South Africa.
2021-01-28

The Philippines signs an agreement with the Serum Institute of India to receive 30 million doses of Novavax's vaccine.
2021-01-10

South Africa is expected to begin a trial of the NVX-CoV2373, a vaccine candidate produced by Novavax. Around 2,904 volunteers are expected to be selected, who are aged from 18 to 64 years.
2020-09-5